Journal
EXPERIMENTAL NEUROLOGY
Volume 167, Issue 1, Pages 196-204Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1006/exnr.2000.7542
Keywords
striatum; excitotoxicity; mGluRs; N-methyl-D-aspartate; quinolinic acid; decortication
Categories
Funding
- NIA NIH HHS [AG13617] Funding Source: Medline
- NINDS NIH HHS [NS31579] Funding Source: Medline
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS031579] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON AGING [R37AG013617, R01AG013617] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Excitotoxic lesions of the striatum are mediated by the combined activity of N-methyl-D-aspartate (NMDA) receptors and metabotropic glutamate receptors (mGluRs). Intrastriatal injection of the NMDA receptor agonists NMDA or quinolinic acid creates large lesions, but in rats that have been decorticated to remove endogenous glutamatergic input, NMDA and quinolinic acid are no longer toxic. We report that NMDA toxicity can be restored in decorticated animals by coinjection of the group I mGluR agonists t-ACPD, t-ADA, or CHPG.. In addition, injections of two group I mGluR antagonists, AIDA and (S)-4C3HPG, can protect against striatal lesions produced by quinolinic acid or NMDA injections in normal rats by blocking activation of group I mGluRs. The group II mGluR agonist APDC fails to protect against quinolinic acid or NMDA toxicity in intact animals or to restore NMDA toxicity in decorticated animals, suggesting that the role of group II receptors in this excitotoxic model is minimal. These observations confirm the important role of group I mGluRs in excitotoxicity and identify these receptors as promising targets for therapeutic intervention in neurodegenerative disease processes, (C) 2001 Academic Press.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available